Our experimental data show that applications of a DA1 antagonist at the precystic stage prevented renal cyst formation only in Pkd2–/–, which had impaired GTB, but not in Pkd1–/–, which had intact GTB. The gene discussed is PKD2; the disease is cystic kidney disease.